Arachidonic acid metabolism via cytosolic phospholipase A 2α induces cytotoxicity in niemann-pick disease type C cells

Journal of Cellular Physiology

Volumn 227, Issue 7, 2012, Pages 2847-2855

  Nakamura, Hiroyuki ^a   Yasufuku, Kana ^a   Makiyama, Tomohiko ^a   Matsumoto, Ikiru ^a   Fujino, Hiromichi ^a   Murayama, Toshihiko ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (2 DIETHYLAMINOETHOXY)ANDROST 5 EN 17 ONE; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LIPOPROTEIN; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2ALPHA; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DEATH; CHO CELL; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; ENZYME INHIBITION; FEMALE; FIBROSARCOMA; GENE SILENCING; MOUSE; NIEMANN PICK DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SARCOMA CELL;

ANDROSTENES; ANIMALS; ARACHIDONIC ACID; CARRIER PROTEINS; CELL CYCLE CHECKPOINTS; CELL DEATH; CHO CELLS; CHOLESTEROL; CRICETINAE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOSOL; DINOPROSTONE; FIBROSARCOMA; GROUP IV PHOSPHOLIPASES A2; MEMBRANE GLYCOPROTEINS; MICE; NIEMANN-PICK DISEASE, TYPE C; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED;

CRICETULUS GRISEUS;

EID: 84858678463     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.23025     Document Type: Article

References (46)

1. Babalola JO, Wendeler M, Breiden B, Arenz C, Schwarzmann G, Locatelli-Hoops S, Sandhoff K. 2007. Development of an assay for the intermembrane transfer of cholesterol by Niemann-Pick C2 protein. Biol Chem 388: 617-626.
2. Balboa MA, Balsinde J. 2006. Oxidative stress and arachidonic acid mobilization. Biochim Biophys Acta 1761: 385-391.
3. 2 induces a transient multi-phase cell cycle arrest in mouse fibroblasts through modulating cyclin D and p21Cip1 expression. J Biol Chem 277: 13761-13770.
4. Bascunan-Castillo EC, Erickson RP, Howison CM, Hunter RJ, Heidenreich RH, Hicks C, Trouard TP, Gillies RJ. 2004. Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C. J Appl Genet 45: 461-467.
5. Baudry M, Yao Y, Simmons D, Liu J, Bi X. 2003. Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: Immunohistochemical observations of microglia and astroglia. Exp Neurol 184: 887-903.
6. Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917.
7. Butler JD, Vanier MT, Pentchev PG. 1993. Niemann-Pick C disease: Cystine and lipids accumulate in the murine model of this lysosomal cholesterol lipidosis. Biochem Biophys Res Commun 196: 154-159.
8. Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, Nagle J, Polymeropoulos MH, Sturley SL, Ioannou YA, Higgins ME, Comly M, Cooney A, Brown A, Kaneski CR, Blanchette-Mackie EJ, Dwyer NK, Neufeld EB, Chang TY, Liscum L, Strauss JF III, Ohno K, Zeigler M, Carmi R, Sokol J, Markie D, O'Neill RR, van Diggelen OP, Elleder M, Patterson MC, Brady RO, Vanier MT, Pentchev PG, Tagle DA. 1997. Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis. Science 277: 228-231.
9. Cooper AJ, Kristal BS. 1997. Multiple roles of glutathione in the central nervous system. Biol Chem 378: 793-802.
10. Demel RA, Jansen JW, van Dijck PW, van Deenen LL. 1977. The preferential interaction of cholesterol with different classes of phospholipids. Biochim Biophys Acta 465: 1-10.
11. Farooqui AA, Horrocks LA, Farooqui T. 2007. Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide. J Neurosci Res 85: 1834-1850.
12. German DC, Liang CL, Song T, Yazdani U, Xie C, Dietschy JM. 2002. Neurodegeneration in the Niemann-Pick C mouse: Glial involvement. Neuroscience 109: 437-450.
13. Grimmer S, Ying M, Walchli S, van Deurs B, Sandvig K. 2005. Golgi vesiculation induced by cholesterol occurs by a dynamin- and cPLA2-dependent mechanism. Traffic 6: 144-156.
14. Higashi Y, Murayama S, Pentchev PG, Suzuki K. 1993. Cerebellar degeneration in the Niemann-Pick type C mouse. Acta Neuropathol 85: 175-184.
15. Hirabayashi T, Murayama T, Shimizu T. 2004. Regulatory mechanism and physiological role of cytosolic phospholipase A2. Biol Pharm Bull 27: 1168-1173.
16. Kishimoto K, Matsumura K, Kataoka Y, Morii H, Watanabe Y. 1999. Localization of cytosolic phospholipase A2 messenger RNA mainly in neurons in the rat brain. Neuroscience 92: 1061-1077.
17. Klapisz E, Masliah J, Bereziat G, Wolf C, Koumanov KS. 2000. Sphingolipids and cholesterol modulate membrane susceptibility to cytosolic phospholipase A(2). J Lipid Res 41: 1680-1688.
18. Klivenyi P, Beal MF, Ferrante RJ, Andreassen OA, Wermer M, Chin MR, Bonventre JV. 1998. Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity. J Neurochem 71: 2634-2637.
19. Koh CH, Whiteman M, Li QX, Halliwell B, Jenner AM, Wong BS, Laughton KM, Wenk M, Masters CL, Beart PM, Bernard O, Cheung NS. 2006. Chronic exposure to U18666A is associated with oxidative stress in cultured murine cortical neurons. J Neurochem 98: 1278-1289.
20. Koike T, Ishida G, Taniguchi M, Higaki K, Ayaki Y, Saito M, Sakakihara Y, Iwamori M, Ohno K. 1998. Decreased membrane fluidity and unsaturated fatty acids in Niemann-Pick disease type C fibroblasts. Biochim Biophys Acta 1406: 327-335.
21. Kriem B, Sponne I, Fifre A, Malaplate-Armand C, Lozac'h-Pillot K, Koziel V, Yen-Potin FT, Bihain B, Oster T, Olivier JL, Pillot T. 2005. Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide. FASEB J 19: 85-87.
22. Kudo I, Murakami M. 2002. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 68-69: 3-58.
23. Kurosawa T, Nakamura H, Yamaura E, Fujino H, Matsuzawa Y, Kawashima T, Murayama T. 2009. Cytotoxicity induced by inhibition of thioredoxin reductases via multiple signaling pathways: Role of cytosolic phospholipase A(2)alpha-dependent and -independent release of arachidonic acid. J Cell Physiol 219: 606-616.
24. Lee JG, Lee SH, Park DW, Lee SH, Yoon HS, Chin BR, Kim JH, Kim JR, Baek SH. 2008. Toll-like receptor 9-stimulated monocyte chemoattractant protein-1 is mediated via JNK-cytosolic phospholipase A2-ROS signaling. Cell Signal 20: 105-111.
25. Leventhal AR, Leslie CC, Tabas I. 2004. Suppression of macrophage eicosanoid synthesis by atherogenic lipoproteins is profoundly affected by cholesterol-fatty acyl esterification and the Niemann-Pick C pathway of lipid trafficking. J Biol Chem 279: 8084-8092.
26. Liscum L. 2000. Niemann-Pick type C mutations cause lipid traffic jam. Traffic 1: 218-225.
27. Liscum L, Faust JR. 1989. The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. J Biol Chem 264: 11796-11806.
28. Lund-Katz S, Laboda HM, McLean LR, Phillips MC. 1988. Influence of molecular packing and phospholipid type on rates of cholesterol exchange. Biochemistry 27: 3416-3423.
29. Nakamura H, Hirabayashi T, Someya A, Shimizu M, Murayama T. 2004. Inhibition of arachidonic acid release and cytosolic phospholipase A2 alpha activity by D-erythro-sphingosine. Eur J Pharmacol 484: 9-17.
30. Nakamura H, Hirabayashi T, Shimizu M, Murayama T. 2006. Ceramide-1-phosphate activates cytosolic phospholipase A2alpha directly and by PKC pathway. Biochem Pharmacol 71: 850-857.
31. Nakamura H, Wakita S, Suganami A, Tamura Y, Hanada K, Murayama T. 2010. Modulation of the activity of cytosolic phospholipase A2alpha (cPLA2alpha) by cellular sphingolipids and inhibition of cPLA2alpha by sphingomyelin. J Lipid Res 51: 720-728.
32. Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, Jadot M, Lobel P. 2000. Identification of HE1 as the second gene of Niemann-Pick C disease. Science 290: 2298-2301.
33. Pappolla MA, Smith MA, Bryant-Thomas T, Bazan N, Petanceska S, Perry G, Thal LJ, Sano M, Refolo LM. 2002. Cholesterol, oxidative stress, and Alzheimer's disease: Expanding the horizons of pathogenesis. Free Radic Biol Med 33: 173-181.
34. Pompeia C, Lima T, Curi R. 2003. Arachidonic acid cytotoxicity: Can arachidonic acid be a physiological mediator of cell death? Cell Biochem Funct 21: 97-104.
35. Saito Y, Suzuki K, Nanba E, Yamamoto T, Ohno K, Murayama S. 2002. Niemann-Pick type C disease: Accelerated neurofibrillary tangle formation and amyloid beta deposition associated with apolipoprotein E epsilon 4 homozygosity. Ann Neurol 52: 351-355.
36. Sanchez-Mejia RO, Newman JW, Toh S, Yu GQ, Zhou Y, Halabisky B, Cisse M, Scearce-Levie K, Cheng IH, Gan L, Palop JJ, Bonventre JV, Mucke L. 2008. Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat Neurosci 11: 1311-1318.
37. Shmelzer Z, Haddad N, Admon E, Pessach I, Leto TL, Eitan-Hazan Z, Hershfinkel M, Levy R. 2003. Unique targeting of cytosolic phospholipase A2 to plasma membranes mediated by the NADPH oxidase in phagocytes. J Cell Biol 162: 683-692.
38. Smith D, Wallom KL, Williams IM, Jeyakumar M, Platt FM. 2009. Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1. Neurobiol Dis 36: 242-251.
39. Suzuki K, Parker CC, Pentchev PG, Katz D, Ghetti B, D'Agostino AN, Carstea ED. 1995. Neurofibrillary tangles in Niemann-Pick disease type C. Acta Neuropathol 89: 227-238.
40. Suzuki M, Sugimoto Y, Ohsaki Y, Ueno M, Kato S, Kitamura Y, Hosokawa H, Davies JP, Ioannou YA, Vanier MT, Ohno K, Ninomiya H. 2007. Endosomal accumulation of Toll-like receptor 4 causes constitutive secretion of cytokines and activation of signal transducers and activators of transcription in Niemann-Pick disease type C (NPC) fibroblasts: A potential basis for glial cell activation in the NPC brain. J Neurosci 27: 1879-1891.
41. te Vruchte D, Lloyd-Evans E, Veldman RJ, Neville DC, Dwek RA, Platt FM, van Blitterswijk WJ, Sillence DJ. 2004. Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport. J Biol Chem 279: 26167-26175.
42. Uozumi N, Shimizu T. 2002. Roles for cytosolic phospholipase A2alpha as revealed by gene-targeted mice. Prostaglandins Other Lipid Mediat 68-69: 59-69.
43. Walkley SU, Suzuki K. 2004. Consequences of NPC1 and NPC2 loss of function in mammalian neurons. Biochim Biophys Acta 1685: 48-62.
44. Wu YP, Mizukami H, Matsuda J, Saito Y, Proia RL, Suzuki K. 2005. Apoptosis accompanied by up-regulation of TNF-alpha death pathway genes in the brain of Niemann-Pick type C disease. Mol Genet Metab 84: 9-17.
45. Yasuda Y, Yoshinaga N, Murayama T, Nomura Y. 1999. Inhibition of hydrogen peroxide-induced apoptosis but not arachidonic acid release in GH3 cell by EGF. Brain Res 850: 197-206.
46. Yeagle PL, Young JE. 1986. Factors contributing to the distribution of cholesterol among phospholipid vesicles. J Biol Chem 261: 8175-8181.